Hodgkin Lymphoma: Treatment and Late Effects

This free course focuses on the case of a 16-year-old girl diagnosed with stage II Hodgkin lymphoma with bulky involvement.  The presentation discusses adult vs. pediatric treatment options, as well as the challenges related to delivery of care for an adolescent patient; also covered is the risk of developing secondary breast cancer later in life and the need for screening in patients with a previous Hodgkin lymphoma diagnosis.    

Learning Objectives:

  • Increase awareness of the differing treatment options for pediatric and adult patients with Hodgkin Lymphoma.
  • Apply knowledge of potential delayed effects of Hodgkin Lymphoma to informing AYA patients of the need for follow-up care.
  • Identify the risk factors for developing secondary breast cancers in patients previously treated for Hodgkin Lymphoma.

CME credit is available for this course.

ACGME Competencies addressed: Medical Knowledge; Practice-based Learning & Improvement; Interpersonal & Communications Skills; Professionalism

This activity is co-sponsored by the LIVESTRONG Foundation, the Commission on Cancer/American College of Surgeons, Critical Mass: The Young Adult Cancer Alliance, the Association of Physician Assistants in Oncology, the American Society of Pediatric Hematology/Oncology, and the Conquer Cancer Foundation of the American Society of Clinical Oncology.

This initiative was supported by the Cooperative Agreement 5U50DP001689-05 from The Centers for Disease Control and Prevention.  Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.

This course, as well as others in the Focus Under Forty Series, was also supported by the LIVESTRONG Foundation.

Create an ASCO Guest ID.